|Articles|December 4, 2014
Biorasi Acquires European CRO, Advanced Biosciences Research
Biorasi LLC announced that it has completed the acquisition of Advanced Biosciences Research
Advertisement
Biorasi LLC, a global CRO, announced that it has completed the acquisition of Advanced Biosciences Research (ABR), a European CRO with operations in United Kingdom, Germany, Switzerland, and Sweden. ABR is a highly integrated group that has provided Phase II to IV clinical research project management, monitoring, and regulatory outsourcing for its sponsors in the region.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
ACT Brief: AI-Enabled End-to-End Trials, New Phase III Data in HIV, and a First-Line Shift in HER2-Positive Breast Cancer
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5